• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA 等位基因调节多发性硬化症中的 EBV 病毒载量。

HLA alleles modulate EBV viral load in multiple sclerosis.

机构信息

Don C. Gnocchi Foundation IRCCS - ONLUS, Piazzale Morandi 3, 20121, Milan, Italy.

Department of Health Sciences, University of Eastern Piedmont, Novara, Italy.

出版信息

J Transl Med. 2018 Mar 27;16(1):80. doi: 10.1186/s12967-018-1450-6.

DOI:10.1186/s12967-018-1450-6
PMID:29587799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5870171/
Abstract

BACKGROUND

The etiopathology of multiple sclerosis (MS) is believed to include genetic and environmental factors. Human leukocyte antigen (HLA) alleles, in particular,  are associated with disease susceptibility, whereas Epstein Barr Virus (EBV) infection has long been suspected to play a role in disease pathogenesis. The aim of the present study is to evaluate correlations between HLA alleles and EBV infection in MS.

METHODS

HLA alleles, EBV viral load (VL) and serum anti-EBV antibody titers were evaluated in EBV-seropositive MS patients (N = 117) and age- and sex-matched healthy controls (HC; N = 89).

RESULTS

Significantly higher DNA viral loads (p = 0.048) and EBNA-1 antibody titer (p = 0.0004) were seen in MS compared to HC. EBV VL was higher in HLA-B07+ (p = 0.02) and HLA-DRB115+ (p = 0.02) MS patients, whereas it was lower in HLA-A02+ (p = 0.04) subjects. EBV VL was highest in HLA-A02-/B07+/DRB115+ patients and lowest in HLA-AA02+/B07-/DRB115- individuals (p < 0.0001). HLA-B07 resulted the most associated allele to EBV VL after multiple regression analysis considering altogether the three alleles, (p = 0.0001). No differences were observed in anti-EBV antibody titers in relationship with HLA distribution.

CONCLUSIONS

Host HLA-B*07 allele influence EBV VL in MS. As HLA-class I molecules present antigens to T lymphocytes and initiate immune response against viruses, these results could support a role for EBV in MS.

摘要

背景

多发性硬化症(MS)的发病机制被认为包括遗传和环境因素。人类白细胞抗原(HLA)等位基因,特别是,与疾病易感性相关,而 Epstein Barr 病毒(EBV)感染长期以来一直被怀疑在疾病发病机制中起作用。本研究旨在评估 MS 中 HLA 等位基因与 EBV 感染之间的相关性。

方法

评估 EBV 血清阳性 MS 患者(N=117)和年龄及性别匹配的健康对照者(HC;N=89)中的 HLA 等位基因、EBV 病毒载量(VL)和血清抗 EBV 抗体滴度。

结果

与 HC 相比,MS 患者的 DNA 病毒载量(p=0.048)和 EBNA-1 抗体滴度(p=0.0004)显著更高。在 HLA-B07+(p=0.02)和 HLA-DRB115+(p=0.02)MS 患者中,EBV VL 更高,而在 HLA-A02+(p=0.04)患者中则更低。在 HLA-A02-/B07+/DRB115+患者中 EBV VL 最高,在 HLA-AA02+/B07-/DRB115-个体中最低(p<0.0001)。在考虑到这三个等位基因的多回归分析后,HLA-B07 是与 EBV VL 最相关的等位基因(p=0.0001)。在与 HLA 分布的关系中,未观察到抗 EBV 抗体滴度的差异。

结论

宿主 HLA-B*07 等位基因影响 MS 中的 EBV VL。由于 HLA-I 类分子将抗原呈递给 T 淋巴细胞并启动针对病毒的免疫反应,这些结果可能支持 EBV 在 MS 中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/1c426e39983f/12967_2018_1450_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/e873f2d678c4/12967_2018_1450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/fffe9cdda82f/12967_2018_1450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/6834991bd646/12967_2018_1450_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/cb816b6746b7/12967_2018_1450_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/527c789be55f/12967_2018_1450_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/1c426e39983f/12967_2018_1450_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/e873f2d678c4/12967_2018_1450_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/fffe9cdda82f/12967_2018_1450_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/6834991bd646/12967_2018_1450_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/cb816b6746b7/12967_2018_1450_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/527c789be55f/12967_2018_1450_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd3/5870171/1c426e39983f/12967_2018_1450_Fig6_HTML.jpg

相似文献

1
HLA alleles modulate EBV viral load in multiple sclerosis.HLA 等位基因调节多发性硬化症中的 EBV 病毒载量。
J Transl Med. 2018 Mar 27;16(1):80. doi: 10.1186/s12967-018-1450-6.
2
Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.结合 HLA-DR 风险等位基因和抗 Epstein-Barr 病毒抗体谱分层多发性硬化症风险。
Mult Scler. 2014 Mar;20(3):286-94. doi: 10.1177/1352458513498829. Epub 2013 Jul 25.
3
Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.儿童多发性硬化症中常见病毒和人类白细胞抗原-DRB1 的抗体反应。
Mult Scler. 2013 Jun;19(7):891-5. doi: 10.1177/1352458512469693. Epub 2012 Dec 11.
4
Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.多发性硬化症中EB病毒核抗原-1特异性潜伏T细胞频率增加及特异性拓宽
Brain. 2006 Jun;129(Pt 6):1493-506. doi: 10.1093/brain/awl067. Epub 2006 Mar 28.
5
Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.科威特多发性硬化症患者中EB病毒抗体反应的性别影响。
J Neuroimmunol. 2015 Aug 15;285:57-61. doi: 10.1016/j.jneuroim.2015.05.021. Epub 2015 May 21.
6
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.当前和过去的 EBV 感染与初始 CNS 脱髓鞘的风险有关。
Neurology. 2011 Jul 26;77(4):371-9. doi: 10.1212/WNL.0b013e318227062a. Epub 2011 Jul 13.
7
Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.整合风险因素:HLA-DRB1*1501与爱泼斯坦-巴尔病毒在多发性硬化症中的作用
Neurology. 2008 Mar 25;70(13 Pt 2):1113-8. doi: 10.1212/01.wnl.0000294325.63006.f8. Epub 2008 Feb 13.
8
Epstein-Barr virus and multiple sclerosis: interaction with HLA.爱泼斯坦-巴尔病毒与多发性硬化症:与 HLA 的相互作用。
Genes Immun. 2012 Jan;13(1):14-20. doi: 10.1038/gene.2011.42. Epub 2011 Jul 21.
9
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.人类白细胞抗原B7/A2、EB病毒抗体之间的基因-环境相互作用与多发性硬化症中的磁共振成像损伤相关。
J Neuroimmunol. 2009 Apr 30;209(1-2):123-30. doi: 10.1016/j.jneuroim.2009.01.023. Epub 2009 Feb 15.
10
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.基因-环境相互作用:爱泼斯坦-巴尔病毒感染与儿童期多发性硬化症风险
Mult Scler. 2024 Mar;30(3):308-315. doi: 10.1177/13524585231224685. Epub 2024 Feb 9.

引用本文的文献

1
Understanding Sex Differences in Autoimmune Diseases: Immunologic Mechanisms.了解自身免疫性疾病中的性别差异:免疫机制。
Int J Mol Sci. 2025 Jul 23;26(15):7101. doi: 10.3390/ijms26157101.
2
Epstein-Barr virus and multiple sclerosis: lesson learned to develop better nonhuman primate models.爱泼斯坦-巴尔病毒与多发性硬化症:为开发更好的非人灵长类动物模型所汲取的经验教训。
Exp Mol Med. 2025 Jun;57(6):1143-1151. doi: 10.1038/s12276-025-01482-5. Epub 2025 Jun 30.
3
A survey of pathogenic involvement in non-communicable human diseases.非传染性人类疾病中致病因素的调查。

本文引用的文献

1
Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.多发性硬化症中爱泼斯坦-巴尔病毒感染的T细胞控制缺陷
Clin Transl Immunology. 2017 Jan 20;6(1):e126. doi: 10.1038/cti.2016.87. eCollection 2017 Jan.
2
A meta-analysis of interaction between Epstein-Barr virus and HLA-DRB1*1501 on risk of multiple sclerosis.爱泼斯坦-巴尔病毒与HLA-DRB1*1501相互作用对多发性硬化症风险影响的荟萃分析。
Sci Rep. 2015 Dec 11;5:18083. doi: 10.1038/srep18083.
3
The burden of multiple sclerosis variants in continental Italians and Sardinians.
Commun Med (Lond). 2025 Jun 20;5(1):242. doi: 10.1038/s43856-025-00956-x.
4
The case for targeting latent and lytic Epstein-Barr virus infection in multiple sclerosis.针对多发性硬化症中潜伏性和裂解性爱泼斯坦-巴尔病毒感染的理由。
Brain. 2025 Sep 3;148(9):3057-3071. doi: 10.1093/brain/awaf170.
5
In-depth analysis of serum antibodies against Epstein-Barr virus lifecycle proteins, and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis.对多发性硬化症患者血清中针对爱泼斯坦-巴尔病毒生命周期蛋白、EBNA1、ANO2、胶质细胞粘附分子和CRYAB肽的抗体进行深入分析。
Front Immunol. 2024 Dec 17;15:1487523. doi: 10.3389/fimmu.2024.1487523. eCollection 2024.
6
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation.DRB1*15:01 限制性 CD4 T 细胞识别两种能够进行细胞内抗原呈递的 Epstein-Barr 病毒糖蛋白。
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2416097121. doi: 10.1073/pnas.2416097121. Epub 2024 Oct 21.
7
Epstein-Barr virus as a potentiator of autoimmune diseases.EB 病毒作为自身免疫性疾病的增强剂。
Nat Rev Rheumatol. 2024 Nov;20(11):729-740. doi: 10.1038/s41584-024-01167-9. Epub 2024 Oct 10.
8
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation.多发性硬化症中更广泛的抗EBV TCR库:疾病特异性与治疗调节
Brain. 2025 Mar 6;148(3):933-940. doi: 10.1093/brain/awae244.
9
EBV and multiple sclerosis: expression of LMP2A in MS patients.爱泼斯坦-巴尔病毒与多发性硬化症:LMP2A在多发性硬化症患者中的表达
Front Neurosci. 2024 Apr 24;18:1385233. doi: 10.3389/fnins.2024.1385233. eCollection 2024.
10
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.针对 Epstein-Barr 病毒的免疫反应的遗传学:多发性硬化症发病机制的前景。
Brain. 2024 Oct 3;147(10):3573-3582. doi: 10.1093/brain/awae110.
意大利大陆地区居民和撒丁岛居民中多发性硬化症变异的负担。
Mult Scler. 2015 Oct;21(11):1385-95. doi: 10.1177/1352458515596599.
4
Class II HLA interactions modulate genetic risk for multiple sclerosis.II类人类白细胞抗原相互作用调节多发性硬化症的遗传风险。
Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.
5
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者脑脊液和血液样本中爱泼斯坦-巴尔病毒DNA的定量检测
PLoS One. 2014 Apr 10;9(4):e94497. doi: 10.1371/journal.pone.0094497. eCollection 2014.
6
Epstein-Barr virus infection: a smoking gun for multiple sclerosis?爱泼斯坦-巴尔病毒感染:多发性硬化症的确凿证据?
Neurology. 2012 Sep 25;79(13):1310-1. doi: 10.1212/WNL.0b013e31826c1baf. Epub 2012 Aug 29.
7
HLA associations in classical Hodgkin lymphoma: EBV status matters.经典型霍奇金淋巴瘤中的 HLA 相关性:EBV 状态很重要。
PLoS One. 2012;7(7):e39986. doi: 10.1371/journal.pone.0039986. Epub 2012 Jul 10.
8
Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.维生素 D 反应元件和 HLA 启动子对多发性硬化症风险的贡献。
Neurology. 2012 Aug 7;79(6):538-46. doi: 10.1212/WNL.0b013e318263c407. Epub 2012 Jul 11.
9
HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.HLA-B7 限制的 EBV 特异性 CD8+ T 细胞在多发性硬化症中失调。
J Immunol. 2012 May 1;188(9):4671-80. doi: 10.4049/jimmunol.1103100. Epub 2012 Mar 28.
10
Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors.鉴定突尼斯多发性硬化症患者和健康献血者中的人类疱疹病毒 1 至 8 型。
J Neurovirol. 2012 Feb;18(1):12-9. doi: 10.1007/s13365-011-0056-z. Epub 2011 Nov 5.